These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 19526064)

  • 1. Expression variation: its relevance to emergence of chronic disease and to therapy.
    Mayburd AL
    PLoS One; 2009 Jun; 4(6):e5921. PubMed ID: 19526064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redefinition of Affymetrix probe sets by sequence overlap with cDNA microarray probes reduces cross-platform inconsistencies in cancer-associated gene expression measurements.
    Carter SL; Eklund AC; Mecham BH; Kohane IS; Szallasi Z
    BMC Bioinformatics; 2005 Apr; 6():107. PubMed ID: 15850491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of AKT independent effects of the synthetic AKT inhibitors SH-5 and SH-6 using an integrated approach combining transcriptomic profiling and signaling pathway perturbations.
    Krech T; Thiede M; Hilgenberg E; Schäfer R; Jürchott K
    BMC Cancer; 2010 Jun; 10():287. PubMed ID: 20546605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive sensitivity analysis of microarray breast cancer classification under feature variability.
    Sontrop HM; Moerland PD; van den Ham R; Reinders MJ; Verhaegh WF
    BMC Bioinformatics; 2009 Nov; 10():389. PubMed ID: 19941644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards precise classification of cancers based on robust gene functional expression profiles.
    Guo Z; Zhang T; Li X; Wang Q; Xu J; Yu H; Zhu J; Wang H; Wang C; Topol EJ; Wang Q; Rao S
    BMC Bioinformatics; 2005 Mar; 6():58. PubMed ID: 15774002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An integration of complementary strategies for gene-expression analysis to reveal novel therapeutic opportunities for breast cancer.
    Bild AH; Parker JS; Gustafson AM; Acharya CR; Hoadley KA; Anders C; Marcom PK; Carey LA; Potti A; Nevins JR; Perou CM
    Breast Cancer Res; 2009; 11(4):R55. PubMed ID: 19638211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta analysis of gene expression changes upon treatment of A549 cells with anti-cancer drugs to identify universal responses.
    Agrawal M; Gadgil M
    Comput Biol Med; 2012 Nov; 42(11):1141-9. PubMed ID: 23063289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SCNrank: spectral clustering for network-based ranking to reveal potential drug targets and its application in pancreatic ductal adenocarcinoma.
    Liu E; Zhang ZZ; Cheng X; Liu X; Cheng L
    BMC Med Genomics; 2020 Apr; 13(Suppl 5):50. PubMed ID: 32241274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactively optimizing signal-to-noise ratios in expression profiling: project-specific algorithm selection and detection p-value weighting in Affymetrix microarrays.
    Seo J; Bakay M; Chen YW; Hilmer S; Shneiderman B; Hoffman EP
    Bioinformatics; 2004 Nov; 20(16):2534-44. PubMed ID: 15117752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
    Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
    Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemosensitivity profile of cancer cell lines and identification of genes determining chemosensitivity by an integrated bioinformatical approach using cDNA arrays.
    Nakatsu N; Yoshida Y; Yamazaki K; Nakamura T; Dan S; Fukui Y; Yamori T
    Mol Cancer Ther; 2005 Mar; 4(3):399-412. PubMed ID: 15767549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Microarray Preprocessing Techniques in Unraveling Biological Pathways.
    Deandrés-Galiana EJ; Fernández-Martínez JL; Saligan LN; Sonis ST
    J Comput Biol; 2016 Dec; 23(12):957-968. PubMed ID: 27494192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of seven methods for producing Affymetrix expression scores based on False Discovery Rates in disease profiling data.
    Shedden K; Chen W; Kuick R; Ghosh D; Macdonald J; Cho KR; Giordano TJ; Gruber SB; Fearon ER; Taylor JM; Hanash S
    BMC Bioinformatics; 2005 Feb; 6():26. PubMed ID: 15705192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNAs as targets for immunosuppressive drug teriflunomide in anti-cancer potential for hepatocellular carcinoma.
    Xu Y; Shen D; Liu J; Xu X; Tu J; Qin L; Jiang L; Qian H; Guo F
    J Mol Histol; 2020 Dec; 51(6):659-673. PubMed ID: 33034797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression Profiles of the Individual Genes Corresponding to the Genes Generated by Cytotoxicity Experiments with Bortezomib in Multiple Myeloma.
    Ghasemi M; Alpsoy S; Türk S; Malkan ÜY; Atakan Ş; Haznedaroğlu İC; Güneş G; Gündüz M; Yılmaz B; Etgül S; Aydın S; Aslan T; Sayınalp N; Aksu S; Demiroğlu H; Özcebe OI; Büyükaşık Y; Göker H
    Turk J Haematol; 2016 Dec; 33(4):286-292. PubMed ID: 27095044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statistical analysis of high-density oligonucleotide arrays: a multiplicative noise model.
    Sásik R; Calvo E; Corbeil J
    Bioinformatics; 2002 Dec; 18(12):1633-40. PubMed ID: 12490448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
    Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
    BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide expression profiling of 8-chloroadenosine- and 8-chloro-cAMP-treated human neuroblastoma cells using radioactive human cDNA microarray.
    Park GH; Choe J; Choo HJ; Park YG; Sohn J; Kim MK
    Exp Mol Med; 2002 Jul; 34(3):184-93. PubMed ID: 12216110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-platform expression microarray performance in a mouse model of mitochondrial disease therapy.
    Zhang Z; Gasser DL; Rappaport EF; Falk MJ
    Mol Genet Metab; 2010 Mar; 99(3):309-18. PubMed ID: 19944634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mechanistic pan-cancer pathway model informed by multi-omics data interprets stochastic cell fate responses to drugs and mitogens.
    Bouhaddou M; Barrette AM; Stern AD; Koch RJ; DiStefano MS; Riesel EA; Santos LC; Tan AL; Mertz AE; Birtwistle MR
    PLoS Comput Biol; 2018 Mar; 14(3):e1005985. PubMed ID: 29579036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.